1 results match your criteria: "Department of Hematology Centre Hospitalier du Mans Le Mans France.[Affiliation]"
Article Synopsis
- * A study evaluated real-world data from 389 DLBCL patients across Europe, focusing on clinical effectiveness and safety outcomes over 30 months.
- * Key findings revealed high survival rates (86% at 12 months) and a significant proportion of patients (82%) achieving a complete response to CT-P10, with adverse events aligning with typical chemotherapy effects, indicating its potential as a viable treatment option for DLBCL.